Business Development News
Search and Filter
Results per Page:
Failed Alzheimer’s drug boosts CAR T-cell therapy
Engineered immune cells get a helping hand in new clinical trial for multiple myeloma patients
Eight promising projects win Evergreen Fund grants to promote commercialization of research
A dozen scientists to receive up to $200K from 3-year-old Fred Hutch program
Study aims to cure blood cancers with transplants that could block HIV, too
10 HIV-positive cancer patients to receive donated cord blood with rare resistance gene
Seattle Times' Pacific NW Magazine profiles Fred Hutch
Seattle Times’ Sunday feature looks at the melding of expertise, drive and technology making new cures possible
A focus on partnerships at Hutch/Merck summit
Research on the immune system aims to stop infectious diseases and cancer
Data drives life sciences boom in Seattle
Hutch leaders, entrepreneurs stress importance of partnerships at Life Science Innovation Northwest conference
Scientists-turned-entrepreneurs share lessons learned launching startups
From venture capital to office space to acquisitions, academics starting companies face a steep learning curve — but there’s help to be found
Seattle mayor eager to realize the future of health care right here
Jenny Durkan addresses local life sciences representatives at Hutch roundtable
Drs. Beverly Torok-Storb, Colleen Delaney receive Seattle AWIS Awards
Honored for excellence in science education, advancement and STEM leadership
Luke Timmerman to scale Mount Everest for Fred Hutch research
Seattle writer will head to the top of the world in Climb to Fight Cancer
Forum at Fred Hutch focuses on the hottest developments in cancer immunotherapy
Immune-based treatments move from the fringes to the spotlight
Good News: GeekWire Award Finalists include Bezos Family Immunotherapy Clinic and Nohla Therapeutics, among others
Celebrating faculty and staff achievements
Good News: $8.8 million NIH grant; Evergreen Fund to accelerate commercialization of research; Hutch United co-chair receives fellowship
Celebrating faculty and staff achievements
Inaugural 'Oncology Summit' addresses academic-industry partnerships
Fred Hutch, Merck co-host inaugural ‘Oncology Summit’ to capture non-profit and for-profit outlooks on cancer care
Beyond immunotherapy: Xconomy forum covers breadth of Seattle’s life sciences scene
Xconomy forum highlights research in vaccines, organ transplants, big data, more
Good News at Fred Hutch
Celebrating faculty and staff achievements
Many immunotherapy trial participants with blood cancer in remission, preliminary results show
High rates of complete remission reported in patients with advanced blood cancers in preliminary results from ongoing immunotherapy trial
Immunotherapy for pancreatic cancer boosts survival more than 75 percent in mice, study finds
Therapy using engineered immune cells offers promise for the ‘disease that desperately needs something new’
Why cancer research needs business development – now more than ever
Meet Fred Hutch’s Dr. Niki Robinson, the woman who’s helping make it happen
'A tidal wave coming': Xconomy Forum focuses on promising treatments
Immunotherapy a key topic at sold-out discussion on the role of biotech in Seattle